Literature DB >> 19881301

Suppressive effects of T-412, a flavone on interleukin-4 production in T cells.

Mirim Jin1, Sunyoung Park, Myoung Yun Pyo.   

Abstract

Interleukin (IL)-4 has been suggested as a molecular therapeutic target to prevent and/or treat various allergic diseases and several flavonoids have been suggested as anti-allergic agents suppressing IL-4 production. In an effort to find novel candidates for anti-allergic agents from natural sources, we screened several flavonoids affecting on IL-4 production. In this study, we showed that 7,8,4'-trihydroxyflavone (T-412) significantly decreased IL-4 production both in phorbol 12-myristate 13-acetate (PMA) and ionomycin (PI)-activated EL-4 T cells and concanavalin A (ConA)-activated murine CD4(+) T cells in a dose- and time-dependent manner. The PI-induced increase of IL-4 mRNA expression was dramatically suppressed by T-412 at 6 h, indicating the suppression is regulated at transcriptional level. T-412 also significantly inhibited IL-4 gene promoter activity in EL-4 T cells transiently transfected with luciferase reporter plasmid containing IL-4 promoter (pGL4.14-IL-4). Western blot analysis of the transcription factors revealed that T-412 suppressed the nuclear expression of nuclear factor of activated T cells (NF-AT)c1, c-Jun and c-Maf, but not c-Fos and nuclear factor kappa B (NF-kappaB). Our data suggested that T-412 might have potential as a candidate for anti-allergic agent having suppressive effects on IL-4 production in activated T cells by controlling the transcription of IL-4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19881301     DOI: 10.1248/bpb.32.1875

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  8-(Tosylamino)quinoline inhibits macrophage-mediated inflammation by suppressing NF-κB signaling.

Authors:  Yongwoo Jung; Se Eun Byeon; Dae Sung Yoo; Yong Gyu Lee; Tao Yu; Yanyan Yang; Ji Hye Kim; Eunji Kim; Deok Jeong; Man Hee Rhee; Eui Su Choung; Sungyoul Hong; Jae Youl Cho
Journal:  Acta Pharmacol Sin       Date:  2012-07-16       Impact factor: 6.150

2.  Nanostructured, self-assembling peptide K5 blocks TNF-α and PGE₂ production by suppression of the AP-1/p38 pathway.

Authors:  Woo Seok Yang; Yung Chul Park; Ji Hye Kim; Hye Ri Kim; Tao Yu; Se Eun Byeon; Larry D Unsworth; Jaehwi Lee; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2012-01-24       Impact factor: 4.711

3.  Extracellular signal-regulated kinase is a direct target of the anti-inflammatory compound amentoflavone derived from Torreya nucifera.

Authors:  Jueun Oh; Ho Sik Rho; Yanyan Yang; Ju Young Yoon; Jongsung Lee; Yong Deog Hong; Hyeon Chung Kim; Sun Shim Choi; Tae Woong Kim; Song Seok Shin; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

4.  N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

Authors:  Ming-Che Chang; Jin-Yi Wu; Hui-Fen Liao; Yu-Jen Chen; Cheng-Deng Kuo
Journal:  Anticancer Drugs       Date:  2015-11       Impact factor: 2.248

5.  IRAK1/4-targeted anti-inflammatory action of caffeic acid.

Authors:  Woo Seok Yang; Deok Jeong; Young-Su Yi; Jae Gwang Park; Hyohyun Seo; Sang Hyun Moh; Sungyoul Hong; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.